Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-10-004647
Filing Date
2010-08-27
Accepted
2010-08-27 16:41:45
Documents
2
Period of Report
2010-08-26

Document Format Files

Seq Description Document Type Size
1 c62643_ex.html 4  
1 c62643_ex.xml 4 5681
2 c62643_ex24-1.htm EX-24.1 6470
  Complete submission text file 0000930413-10-004647.txt   14205
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 222 S 15TH STREET SUITE 600 N OMAHA NE 68102
Business Address
LEBUHN ROBERT (Reporting) CIK: 0001007931 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 101044462